Xospata leads latest CHMP recommendations
The committee has recommended seven medicines for approval at its September 2019 meeting. [...]
Fri, Sep 20, 2019
Tresiba lowers risk of hypos in type II diabetes
Tresiba significantly reduced the rate of severe hypoglycaemia by 80% and nocturnal symptomatic hypoglycaemia by 37%. [...]
Fri, Sep 20, 2019
Sertraline improves anxiety, but ‘unlikely’ to treat depression
The findings support the prescription of SSRI antidepressants in a wider group of participants than previously thought. [...]
Fri, Sep 20, 2019
‘New era’ of precision medicine for children with cancer
only 7% of children with targetable mutations were able to access the appropriate adult drug in a study. [...]
Fri, Sep 20, 2019

 

The Learning  Partnership